Lion, GeneProt Partner on Protein Informatics
Lion Bioscience and GeneProt plan to market an “integrated offering” that will marry GeneProt’s proteomics technology with Lion’s bioinformatics tools.
Under the three-year collaboration, GeneProt will license Lion’s SRS and DiscoveryCenter software together with its PiScout and PathScout technologies. The North Brunswick, NJ-based company will also spend up to $4.95 million on “related” services from Lion.
Heidelberg, Germany-based Lion will use GeneProt’s proteomics technology in its in-house drug-discovery efforts and will make a $7.5 million equity investment in GeneProt in exchange for 681,818 shares of Series B stock.
GeneProt intends to use Lion’s software to bolster its own internal information platform, which it will then bundle with Lion’s software and market with its proteomics data to joint customers “at Lion’s discretion.”
BioTools Selected for HIV Analysis Project at VaxGen
BioTools of Edmonton, Alberta, Canada, signed an agreement with VaxGen last week to develop customized software for the analysis of data from VaxGen’s library of HIV-infected plasma samples.
Further details of the “protein and genomic analysis” software under development were not disclosed.
BioTools’ software “will enable us to conduct thorough and rapid analysis of the data from this library to better understand viral variation in HIV and confirm the most biologically and immunologically important regions of the virus,” said David Jobes, sequencing group leader at VaxGen.
EBS is Now Aneda
Edinburgh Biocomputing Systems is changing its name to Aneda Limited, “To reflect the broadening and rapidly developing capabilities of the business,” according to the company.
“Aneda is actually an ancient word for Edinburgh and, as we intend to continue the development of the business here at Roslin, close to the city, it seemed an excellent choice for our new identity,” said Aidan Courtney, commercial director of Aneda.
The company, which markets the MPSRCH search tool, said that it has begun to use its proprietary technology as part of a number of new research partnerships. The first such agreement, with PPL Therapeutics, was announced earlier this year.
Aneda said it expects to launch its next generation of software tools, including a genome-genome comparison package, this spring.